Inari Medical, Inc.
NASDAQ:NARI
46.52 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 493.632 | 383.471 | 276.984 | 139.67 | 51.129 | 6.829 |
| Cost of Revenue
| 64.868 | 44.506 | 24.757 | 13.106 | 5.91 | 1.281 |
| Gross Profit
| 428.764 | 338.965 | 252.227 | 126.564 | 45.218 | 5.548 |
| Gross Profit Ratio
| 0.869 | 0.884 | 0.911 | 0.906 | 0.884 | 0.812 |
| Reseach & Development Expenses
| 87.533 | 74.221 | 51.018 | 18.399 | 7.22 | 3.99 |
| General & Administrative Expenses
| 343.663 | 291.886 | 190.021 | 89.413 | 37.197 | 10.698 |
| Selling & Marketing Expenses
| 1.2 | 0.957 | 0.344 | 0.333 | 0.09 | 0 |
| SG&A
| 344.863 | 292.843 | 190.365 | 89.746 | 37.197 | 10.698 |
| Other Expenses
| 2.861 | 0.356 | -0.018 | -0.662 | -0.205 | -0.133 |
| Operating Expenses
| 432.396 | 367.064 | 241.383 | 108.145 | 44.417 | 14.688 |
| Operating Income
| -3.632 | -28.099 | 6.672 | 18.419 | 0.801 | -9.14 |
| Operating Income Ratio
| -0.007 | -0.073 | 0.024 | 0.132 | 0.016 | -1.338 |
| Total Other Income Expenses Net
| 7.878 | 1.914 | 4.013 | -4.63 | -1.993 | -0.218 |
| Income Before Tax
| 4.246 | -26.185 | 10.685 | 13.789 | -1.192 | -10.153 |
| Income Before Tax Ratio
| 0.009 | -0.068 | 0.039 | 0.099 | -0.023 | -1.487 |
| Income Tax Expense
| 5.882 | 3.082 | 0.845 | -0.912 | 0.715 | -0.126 |
| Net Income
| -1.636 | -29.267 | 9.84 | 13.789 | -1.907 | -10.153 |
| Net Income Ratio
| -0.003 | -0.076 | 0.036 | 0.099 | -0.037 | -1.487 |
| EPS
| -0.029 | -0.55 | 0.2 | 0.43 | -0.04 | -0.23 |
| EPS Diluted
| -0.029 | -0.55 | 0.18 | 0.27 | -0.04 | -0.23 |
| EBITDA
| 7.113 | -18.772 | 10.98 | 18.241 | 1.299 | -8.898 |
| EBITDA Ratio
| 0.014 | -0.049 | 0.04 | 0.131 | 0.025 | -1.303 |